EXSCISSOR
Live / Allowed — Notice of allowance issued (as of 04 Nov 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 28 Jun 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98623888
- Mark type
- Stylized text
- Filed
- 28 Jun 2024
- Published for opposition
- 09 Sept 2025
- Attorney of record
- Jonathan M. Gelchinsky
Goods and services
- Class 042 — Scientific and technological services: Research and development in the field of gene, genome, or cellular editing technology for medical purposes
- Class 045 — Legal and security services: Licensing of intellectual property rights related to gene, genome, or cellular editing technology
Owner
- Intellia Therapeutics, Inc., Cambridge, MA, US
- Intellia Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 04 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Sept 2025 — PUBLISHED FOR OPPOSITION
- 03 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Aug 2025 — EXAMINER'S AMENDMENT ENTERED
- 09 Aug 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 09 Aug 2025 — EXAMINERS AMENDMENT E-MAILED
- 09 Aug 2025 — EXAMINERS AMENDMENT -WRITTEN
- 15 Apr 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 15 Apr 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 16 Jan 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Jan 2025 — NON-FINAL ACTION E-MAILED
- 16 Jan 2025 — NON-FINAL ACTION WRITTEN
- 16 Jan 2025 — ASSIGNED TO EXAMINER